asymmetric bispecific IgG4 antibody that binds to blood clotting factor IXa and factor X. Emicizumab is used for the treatment of patients with hemophilia A, a hereditary bleeding disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback